Cash & equivalents decreased 25.4%
Cash & equivalents changed -25.4% from the comparable as-filed period. The change ranks at the 7th percentile of 60 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -25.4% from the comparable as-filed period. The change ranks at the 7th percentile of 60 prior comparable changes.
Gross margin changed +2661 basis points from the comparable as-filed period. The change ranks at the 29th percentile of 28 prior comparable changes.
Gross profit changed +186.9% from the comparable as-filed period. The change ranks at the 82th percentile of 28 prior comparable changes.
Inventory changed -21.0% from the comparable as-filed period. The change ranks at the 32th percentile of 28 prior comparable changes.
Net income changed +25.4% from the comparable as-filed period. The change ranks at the 54th percentile of 56 prior comparable changes.
Operating income changed +25.0% from the comparable as-filed period. The change ranks at the 59th percentile of 34 prior comparable changes.
Operating margin changed +3507 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 28 prior comparable changes.
Revenue changed +27.2% from the comparable as-filed period. The change ranks at the 32th percentile of 28 prior comparable changes.
Research & development changed +13.7% from the comparable as-filed period. The change ranks at the 47th percentile of 34 prior comparable changes.
Selling, general & administrative changed +10.2% from the comparable as-filed period. The change ranks at the 44th percentile of 34 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.